glp -1 agonist glp-1_analogs [TUSOM Clinical Focus on GLP-1 Agonists

Explore natural alternatives to GLP-1 drugs like Ozempic and Mounjaro

Partly through these actions, GLP-1 receptor agonism was shown to reduce cardiovascular disease (CVD) in people with T2D with previous CVD or at high-risk thereof

The GLP-1 receptor agonist market size was exhibited at USD 36.95 billion in 2023 and is projected to hit around USD 261.19 billion by 2033, growing at a CAGR of 21.6% during the forecast period 2024 to 2033.

Considerations regarding adverse effects and contraindications for different drug classes are provided to help guide treatment decision-making when considering pharmacotherapy for weight management in patients with obesity.

Find out more here.

Scientifically Formulated & Botanical Extracts - Our advanced formula combines probiotics with GLP-1 support with Plant based, Low FODMAP, Non-GMO, Keto-Friendly, Soy-Free, and Nothing Artificial, Light Smell